KYLE LEFKOFF Insider Trading $MGEN Viridian Therapeutics, Inc.\DE
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KYLE LEFKOFF.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KYLE LEFKOFF. KYLE LEFKOFF is in ARRAY BIOPHARMA INC ($ARRY) and Director in ARRAY BIOPHARMA INC ($ARRY) and Director in MIRAGEN THERAPEUTICS, INC. ($SGNL).
KYLE LEFKOFF in Viridian Therapeutics, Inc.\DE
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of KYLE LEFKOFF: Director
Holdings: 466,773 shares
Current Value: $4,924,455
Latest Transaction: Jun 30 2017
$MGEN Market Capitalization: $9.56M
$MGEN Previous Close: $10.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KYLE LEFKOFF in Viridian Therapeutics, Inc.\DE
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30 2017 | MGEN | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Option Exercise | A | 12.06 | 12,000 | 144,720 | 12,000 | |
| Mar 13 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 14.31 | 3,300 | 47,229 | 463,473 | 466.8 K to 463.5 K (-0.71 %) |
| Mar 13 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 14.38 | 2,500 | 35,962 | 466,773 | 469.3 K to 466.8 K (-0.53 %) |
| Mar 08 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 14.70 | 5,000 | 73,514 | 469,273 | 474.3 K to 469.3 K (-1.05 %) |
| Mar 08 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 16.24 | 608 | 9,874 | 474,273 | 474.9 K to 474.3 K (-0.13 %) |
| Mar 08 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 15.71 | 9,392 | 147,590 | 474,881 | 484.3 K to 474.9 K (-1.94 %) |
| Feb 28 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 13.54 | 2,258 | 30,580 | 484,273 | 486.5 K to 484.3 K (-0.46 %) |
| Feb 28 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 13.79 | 1,500 | 20,687 | 486,531 | 488 K to 486.5 K (-0.31 %) |
| Feb 28 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 14.04 | 6,500 | 91,252 | 488,031 | 494.5 K to 488 K (-1.31 %) |
| Feb 24 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 13.65 | 1,800 | 24,566 | 494,531 | 496.3 K to 494.5 K (-0.36 %) |
| Feb 24 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 14.36 | 4,102 | 58,886 | 496,331 | 500.4 K to 496.3 K (-0.82 %) |
Page: 1